Evidence map›Paper›PMID 32631819›Full record

ArticleAntimicrobial agents and chemotherapy2020

Ellie J C Goldstein, C Vreni Merriam, Diane M Citron

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Molecular basis of linezolid resistance inAntimicrobial agents and chemotherapy · 2026
    Article
  2. ThePeerJ · 2025
    Review
  3. Review
  4. Review
  5. Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.Frontiers in cellular and infection microbiology · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ellie J C GoldsteinR. M. Alden Research Laboratory, Santa Monica, California, USA ejcgmd@aol.com.ORCID 0000-0002-1044-6159
C Vreni MerriamR. M. Alden Research Laboratory, Santa Monica, California, USA.
Diane M CitronR. M. Alden Research Laboratory, Santa Monica, California, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tedizolid's anaerobic activity is unappreciated. In this study, it was active against all 332 anaerobic isolates tested at ≤2 μg/ml except

Indexed as

Anti-Infective AgentsPrevotellaAnaerobiosisAnti-Bacterial AgentsBacteria, AnaerobicBacteroides fragilisLinezolidMicrobial Sensitivity TestsOxazolidinonesPorphyromonasTetrazolesVeillonellaAnti-Bacterial AgentsAnti-Infective AgentsLinezolidOxazolidinonestedizolidTetrazolesanaerobesBacteroides fragilislinezolidPrevotella spp.tedizolidVeillonella spp.

Identifiers

PMID32631819
PMCPMC7449201
OpenAlexW3041845684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.